Anavex Life Sciences secures $50M stock purchase deal with Lincoln Park

Oct. 26, 2015 12:43 PM ETAnavex Life Sciences Corp. (AVXL)AVXLBy: Douglas W. House, SA News Editor21 Comments
  • Anavex Life Sciences (AVXL) inks a stock purchase agreement with Lincoln Park Capital Fund, LLC for the sale of up to $50M of common stock over a 36-month period. The company also issued 179,598 shares to Lincoln as a commitment fee.
  • Net proceeds will fund the clinical development of ANAVEX 2-73, its potential treatment for Alzheimer's disease, and general corporate purposes.

Recommended For You

Comments (21)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.